中文名 | Torin 2 |
英文名 | Torin 2 |
别名 | 化合物TORIN 2 6-萘啶-2(1H)-酮 MTOR抑制剂(TORIN 2) 9-(6-氨基-3-吡啶基)-1-[3-(三氟甲基)苯基]苯并[H]-1 9-(6-氨基-3-吡啶基)-1-[3-(三氟甲基)苯基]苯并[H]-1,6-萘啶-2(1H)-酮 |
英文别名 | Torin 2 9-(6-AMino-pyridin-3-yl)-... 9-(6-AMino-pyridin-3-yl)-1-(3-trifluoroMethyl-phenyl)-1H-benzo[h][1,6]naphthyridin-2-one 9-(6-Amino-3-pyridinyl)-1-[3-(trifluoromethyl)phenyl]benzo[h]-1,6-naphthyridin-2(1H)-one Benzo[h]-1,6-naphthyridin-2(1H)-one, 9-(6-amino-3-pyridinyl)-1-[3-(trifluoromethyl)phenyl]- 9-(6-Amino-3-pyridinyl)-1-[3-(trifluoromethyl)phenyl]benzo[h]-1,6-naphthyridin-2(1H)-one Torin 2 Torin 2 9-(6-Amino-3-pyridinyl)-1-[3-(trifluoromethyl)phenyl]benzo[h]-1,6-naphthyridin-2(1H)-one |
CAS | 1223001-51-1 |
化学式 | C24H15F3N4O |
分子量 | 432.4 |
密度 | 1.427 |
熔点 | >275° C (dec.) |
沸点 | 623.7±55.0 °C(Predicted) |
溶解度 | 氯仿 (微溶),DMSO (微溶),甲醇 (微溶,加热) |
酸度系数 | 5.66±0.26(Predicted) |
存储条件 | 2-8°C |
外观 | 粉末 |
颜色 | white to beige |
体外研究 | Torin 2 has the same binding mode as PI3Kγ, V882 serves as a hinge binding point and in the inner hydrophobic pocket Y867, D841 and D964 provide three more hydrogen bonds with aminopyridine side chain analogous to Y2225, D2195 and D2357 of mTOR. Torin 2 inhibits mTORC1, thus activates TFEB by promoting its nuclear translocation with EC50 of 1.666 mM. Torin 2(< 50 nM) causes a significant reduction in viability of both MZ-CRC-1 and TT cells. Torin 2 (100 nM) exerts a significant reduction of migration of both MZ-CRC-1 and TT cells. Torin 2与PI3Kγ具有相同的结合模式,V882作为铰链结合点,在内部疏水袋Y867,D841 和D964再提供三个作用于氨基比林侧链的氢键,类似于mTOR的Y2225,D2195 和D2357。 Torin 2抑制mTORC1,因此通过促进其核转运激活TFEB,EC50为1.666 mM。 Torin 2(< 50 nM)引起MZ-CRC-1和TT细胞的活性显著减少。Torin 2 (100 nM)使MZ-CRC-1和TT细胞的迁移显著减少。 |
体内研究 | Torin 2 exhibits >95% pharmacodynamic response and half-time of 11.7 min in the mouse liver microsome stability study. Torin 2 exhibits the best bioavailability (51%), short half-life (0.72 hours) and low clearance(19.6 mL/min/kg) in male Swiss albino mice following intravenous and oral administration. Torin 2(20mg/kg) ablates MYCN tumors with reduction in MYCN protein levels and induction of apoptosis in Th-MYCN mice. 在小鼠肝微粒体稳定性试验中,Torin 2表现出>95%的药效学响应,和11.7分钟的半衰期。Torin 2静脉内或口服给药后,在雄性Swiss albino小鼠体内表现出最好的生物利用度(51%),短 的半衰期(0.72小时)和低清除率(19.6 mL/min/kg)。 在Th-MYCN 小鼠体内,Torin 2(20mg/kg)消除MYCN肿瘤,减少MYCN蛋白质水平,并诱导细胞凋亡。 |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!